| Naam | Stichting Tuberculosis Vaccine Initiative |
|---|---|
| Website | http://www.tbvi.eu |
| Samenvatting | Accelerating TB Vaccine R&D ThroughPartnership Our projects Our partners Our Work TBVI identifies, develops and coordinates projects and facilitates the |
| Socials |
Biofabri appoints Rolando Pajón to strengthen the late-stage development of its Tuberculosis Vaccine Candidate The appointment comes at a key stage of the project, as MTBVAC advances toward the final phases of clinical...
On 12 February 2026, an open online consultation meeting on the TB Vaccine Development Pathway brought together experts and stakeholders to review its recent renewal and gather input for further improvements. This consu...
On January 27-28, 2026, the TBVI symposium took place in Les Diablerets, Switzerland, attracting over 115 researchers, developers, funders, and policymakers focused on tuberculosis (TB) vaccine research. TBVI thanks all...
Call for Early Career Researchers to join the CTVD meeting The 2026 Collaboration for TB Vaccine Discover (CTVD) Annual Meeting will take place in Nairobi, Kenya June 8-11, 2026. As in years past, CTVD will be offering...
Diversifying the vaccine development pipeline has been recognized as a priority in the Global TB Vaccine R&D Roadmap. The TBVAC-HORIZON consortium has successfully secured funding for an ambitious four-year project that...
To diversify the TB Vaccine pipeline and accelerate TB Vaccine development, scientific innovations are crucial. Both successful new approaches and unexpected negative results need to be communicated widely to enable eff...
8th Global Forum for TB Vaccines to be held in April 2027 in Zaragoza, Spain The University of Zaragoza has announced in a press release that it will host the next edition of the Forum. Read the full article here.
WHO launches the Global TB Report 2025 The World Health Organization (WHO) has released the Global Tuberculosis (TB) Report 2025. This report offers a thorough and current evaluation of the TB epidemic, as well as progr...
Announcement Awardees | TBVI Awards 2026 The TBVI Award aims to encourage promising scientists by recognising their outstanding contributions to tuberculosis (TB) vaccine research and development. It offers them a platf...
MTBVAC caused similar or stronger immune responses compared to the Bacille Calmette-Guérin (BCG) vaccine. NEW YORK, USA, PORRIÑO, SPAIN, CAPE TOWN, SOUTH AFRICA – April 22, 2025 – IAVI, Biofabri, the University of Zarag...
